3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Neoplasms
3
Depression
3
Breast Neoplasms
2
Anxiety Disorders
2
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Hospice
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Gynecologic Cancer
1
Gastrointestinal Neoplasms
1
Emotional Regulation
1
Colonic Neoplasms
1
Advanced Cancer
1
Acute Pain
1
Interventions
Psychotherapy
1
Psilocybin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hospice
×
Psychotherapy
×
Clear all
NCT04950608
2026-02-17
PATH
Dana-Farber Cancer Institute
Phase 2
Completed
15 enrolled
26 charts